HONG KONG -- (MARKET WIRE) -- October 18, 2006 -- AlphaRx International Holdings Limited ("AIH"), subsidiary of AlphaRx Inc. (OTCBB: ALRX), announces that they are entering into the multi billion dollars oncology market with two nanotechnology based products, to address hepatic and lung cancer respectively.
